Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MILONE, Gustavo")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 16 of 16

  • Page / 1
Export

Selection :

  • and

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy : characteristics, outcome, and prognostic factorsMONTESINOS, Pau; BERGUA, Juan M; RIVAS, Concha et al.Blood. 2009, Vol 113, Num 4, pp 775-783, issn 0006-4971, 9 p.Article

Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantationEMILCE ALEJANDRE, Mariel; ARTURO PAVLOVSKY, Miguel; BRESCIANI, Pablo et al.Clinical chemistry and laboratory medicine. 2012, Vol 50, Num 6, pp 1093-1097, issn 1434-6621, 5 p.Article

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trialSALLES, Gilles; SEYMOUR, John Francis; CABALLERO, Dolores et al.Lancet (British edition). 2011, Vol 377, Num 9759, pp 42-51, issn 0140-6736, 10 p.Article

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupTALLMAN, Martin S; KIM, Haesook T; GONZALEZ, Marcos et al.Blood. 2010, Vol 116, Num 25, pp 5650-5659, issn 0006-4971, 10 p.Article

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicinDE LA SERNA, Javier; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2008, Vol 111, Num 7, pp 3395-3402, issn 0006-4971, 8 p.Article

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensMONTESINOS, Pau; RAYON, Chelo; RIVAS, Concha et al.Blood. 2011, Vol 117, Num 6, pp 1799-1805, issn 0006-4971, 7 p.Article

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based ChemotherapyMONTESINOS, Pau; GONZALEZ, José D; DEBEN, Guillermo et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3872-3879, issn 0732-183X, 8 p.Article

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remissionLITZOW, Mark R; PEREZ, Waleska S; MARKS, David I et al.British journal of haematology. 2002, Vol 119, Num 4, pp 1115-1124, issn 0007-1048, 10 p.Article

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyCERVERA, José; MONTESINOS, Pau; MILONE, Gustavo et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 424-431, issn 0390-6078, 8 p.Article

Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experienceALEJANDRE, Mariel Emilce; MADALENA, Leticia Bibiana; PAVLOVSKY, Miguel Arturo et al.Clinical chemistry and laboratory medicine. 2010, Vol 48, Num 5, pp 727-731, issn 1434-6621, 5 p.Article

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcomeSANZ, Miguel A; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2010, Vol 115, Num 25, pp 5137-5146, issn 0006-4971, 10 p.Article

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy : long-term outcome of the LPA 99 multicenter study by the PETHEMA GroupSANZ, Miguel A; MONTESINOS, Pau; RIVAS, Concha et al.Blood. 2008, Vol 112, Num 8, pp 3130-3134, issn 0006-4971, 5 p.Article

Autologous stem cell transplantation for patients with chronic myeloid leukemia: The Argentine Group of Bone Marrow Transplantation (GATMO) ExperienceKOZINER, Benjamin; DENGRA, Cristina; KUSMINSKY, Gustavo et al.Cancer. 2002, Vol 95, Num 11, pp 2339-2345, issn 0008-543X, 7 p.Article

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupSANZ, Miguel A; MARTIN, Guillermo; DE LA SERNA, Javier et al.Blood. 2004, Vol 103, Num 4, pp 1237-1243, issn 0006-4971, 7 p.Article

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: Delayed transplantation for low-risk myelodysplasia is associated with improved outcomeCUTLER, Corey S; LEE, Stephanie J; LAZARUS, Hillard M et al.Blood. 2004, Vol 104, Num 2, pp 579-585, issn 0006-4971, 7 p.Article

Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysisKUMAR, Shaji; ZHANG, Mei-Jie; FREYTES, Cesar O et al.Blood. 2011, Vol 118, Num 7, pp 1979-1988, issn 0006-4971, 10 p.Article

  • Page / 1